Daglutril Completed Phase 2 Trials for Hypertension Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00160225Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension
NCT00160212Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension